Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Vanguard Real Estate Index Fund ETF — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Vanguard Real Estate Index Fund ETF trades at $90.38 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 72.8× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, Vanguard Real Estate Index Fund ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Vanguard Real Estate Index Fund ETF for 113 Days on average.
| MRVI | VNQ | |
|---|---|---|
Market Cap | $972.90M | $70.80B |
Volume | 4,325,710 | 3,568,223 |
Sector | Health | — |
52-Week High | $9.00 | $100.95 |
52-Week Low | $2.83 | $87.00 |
Typical Hold Time | 0 Days | 113 Days |
Enterprise Value | $1.08B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
VNQ, the Vanguard Real Estate ETF, trades at $91.14, down 0.24% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. Recent news highlights pressure from rising Treasury yields and Fed rate hikes, contributing to a nearly 10% decline over the past month. The ETF's dividend yield is now competitive with T-bills, but sector headwinds persist due to interest rate sensitivity.
Outlook remains cautious amid interest rate uncertainty, with potential long-term value for contrarian investors. Risks include further rate hikes eroding income appeal, while opportunities lie in historically attractive entry points for well-capitalized REITs. Investors should weigh yield sustainability against macroeconomic trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
